Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters

[1]  Atique U. Ahmed,et al.  A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma. , 2015, Human gene therapy.

[2]  Atique U. Ahmed,et al.  Neural Stem Cell‐Mediated Delivery of Oncolytic Adenovirus , 2015, Current protocols in human genetics.

[3]  T. Preiss,et al.  Probe‐Directed Degradation (PDD) for Flexible Removal of Unwanted cDNA Sequences from RNA‐Seq Libraries , 2015, Current protocols in human genetics.

[4]  Jacob S. Young,et al.  Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. , 2015, Neuro-oncology.

[5]  M. Barry,et al.  Amplified and Persistent Immune Responses Generated by Single-Cycle Replicating Adenovirus Vaccines , 2014, Journal of Virology.

[6]  M. Varvares,et al.  Evaluation of apoptogenic adenovirus type 5 oncolytic vectors in a Syrian hamster head and neck cancer model , 2014, Cancer Gene Therapy.

[7]  S. Rabkin,et al.  Oncolytic Viruses and Their Application to Cancer Immunotherapy , 2014, Cancer Immunology Research.

[8]  H. Inoue,et al.  Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments , 2013, Cell Death and Differentiation.

[9]  D. Bartlett,et al.  Oncolytic viruses as therapeutic cancer vaccines , 2013, Molecular Cancer.

[10]  Atique U. Ahmed,et al.  The Timing of Neural Stem Cell‐Based Virotherapy Is Critical for Optimal Therapeutic Efficacy When Applied With Radiation and Chemotherapy for the Treatment of Glioblastoma , 2013, Stem cells translational medicine.

[11]  Atique U. Ahmed,et al.  A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy. , 2013, Journal of the National Cancer Institute.

[12]  Atique U. Ahmed,et al.  Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making? , 2013, Future virology.

[13]  Atique U. Ahmed,et al.  Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice , 2013, Front. Oncol..

[14]  Atique U. Ahmed,et al.  Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  W. Wold,et al.  Increasing the Efficacy of Oncolytic Adenovirus Vectors , 2010, Viruses.

[16]  S. Nandi,et al.  Adenoviral virotherapy for malignant brain tumors , 2009, Expert opinion on biological therapy.

[17]  A. Sonabend,et al.  Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats , 2009, Cancer Gene Therapy.

[18]  A. Sonabend,et al.  Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo , 2009, British Journal of Cancer.

[19]  T. He,et al.  Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy. , 2009, International journal of oncology.

[20]  A. Rivera,et al.  Evaluation of E1A double mutant oncolytic adenovectors in anti‐glioma gene therapy , 2008, Journal of medical virology.

[21]  L. Molinero,et al.  Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells. , 2008, Cancer research.

[22]  Z. Guo,et al.  Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. , 2008, Biochimica et biophysica acta.

[23]  A. Rivera,et al.  Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma. , 2007, Human gene therapy.

[24]  I. Ulasov,et al.  Fiber‐knob modifications enhance adenoviral tropism and gene transfer in malignant glioma , 2007, The journal of gene medicine.

[25]  R. Crystal,et al.  CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. , 1999, The Journal of clinical investigation.